… liver disease processes. A limitation regarding disease quantification is that liver disease
of any type (LD) is characteristically nonuniform; a biopsy from the liver periphery from one …

… of dual-echo, chemical shift gradientecho MRI to predict the degree of steatosis on liver biopsy.
… detection of steatosis in patients with nonalcoholic fatty liver disease (NAFLD) using com- …

… Nonalcoholic fatty liver disease (NAFLD) is an emerging epidemic in Western countries and
affects all ages and ethnicities ( , 1, , 2). NAFLD can progress to nonalcoholic steatohepatitis…

… patients without chronic liver disease from 2D, … liver disease is usually associated with
mild-to-severe iron overload [13], which is a known confounder of fat quantification by dual-echo …

… by using a gradient-recalled-echo ( GRE ) … , fatty liver disease is a major cause of chronic
liver disease in the pediatric and young adult population, and patients with fatty liver disease …

… to retrospectively determine the relative accuracy of liver fat quantification with out-of-phase
gradient-echo MR imaging and fat-saturated fast spin-echo MR imaging in patients with and …

… The past decade has witnessed an epidemic increase in nonalcoholic fatty liver disease (NAFLD),
which may affect 10%–30% of adults in the general population ( , 1– , 3) and 13% of …

… The indications of liver MRI were as follows: chronic liver disease follow-up and … , focal liver
lesions (n = 4), and elevated liver enzymes (n = 2). The etiologies of the chronic liver disease …

… of diffuse liver disorders is well documented (1-4). Nonalcoholic fatty liver disease (NAFLD)
is … as the most common cause of chronic liver disease, afflicting an estimated 14% to 30% of …

… dominant polycystic liver disease are usually asymptomatic, with liver dysfunction … disease
can result in hepatomegaly, liver failure, or Budd-Chiari syndrome. Polycystic liver disease …